Publications
5900 Results
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 12136 poster
- Year
- 2026
- Research Committee(s)
- Breast
- Study Number(s)
- S0221
Role of pretreatment vitamin D insufficiency in racial disparity in taxane-induced peripheral neuropathy: Results from the SWOG S0221 trial
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs e21005 pub only e21005
- Year
- 2026
The SWOG Mentoring Advanced Practice Providers (MAPP) program
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 1543 poster 267; J Clin Oncol 44, 2026 (suppl 17; abstr 1543) DOI: 10.1200/JCO.2026.44.17_suppl.1543
- Year
- 2026
- Research Committee(s)
- Cancer Care Delivery
Participation of Older Adults (=65 Years) in SWOG Cancer Clinical Trials
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 5096 poster 191; J Clin Oncol 44, 2026 (suppl 16; abstr 5096) DOI: 10.1200/JCO.2026.44.16_suppl.5096
- Year
- 2026
- Research Committee(s)
- Genitourinary
- Study Number(s)
- S1216
Correlation of baseline testosterone (T) level with survival outcomes in patients (Pts) with metastatic hormone-sensitive prostate cancer (mHSPC): Analysis of patient (pt)–level data from SWOG 1216 study
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs TPS5149 poster 235a; J Clin Oncol 44, 2026 (suppl 16; abstr TPS5149) DOI: 10.1200/JCO.2026.44.16_suppl.TPS5149
- Year
- 2026
- Research Committee(s)
- Genitourinary
- Study Number(s)
- CCTG-PR26
TRIPLE-SWITCH (SWOG/CCTG-PR26): A randomized phase III clinical trial for the addition of docetaxel to androgen receptor pathway inhibitors in patients with metastatic castration sensitive prostate cancer (mCSPC) and suboptimal PSA response (NCT06592924)
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 3630 poster 397; J Clin Oncol 44, 2026 (suppl 16; abstr 3630) DOI: 10.1200/JCO.2026.44.16_suppl.3630
- Year
- 2026
- Research Committee(s)
- Gastrointestinal
- Study Number(s)
- CTSU/C80702
Lycopene and survival in patients with stage III colon cancer: Findings from CALGB (Alliance)/SWOG 80702
- Journal / Conference
- ASCO Annual Meeting (May 29 - June 2, 2026, Chicago, Il); abs 8549 poster 339; J Clin Oncol 44, 2026 (suppl 16; abstr 8549) DOI: 10.1200/JCO.2026.44.16_suppl.8549
- Year
- 2026
- Research Committee(s)
- Lung
- Study Number(s)
- S0819
Baseline CT-derived QVT score as predictor of bevacizumab benefit in advanced non-squamous NSCLC: A retrospective biomarker analysis of SWOG S0819
- Journal / Conference
- J Natl Cancer Inst . 2026 Jul 2:djag216. doi: 10.1093/jnci/djag216. Online ahead of print.
- Year
- 2026
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- 42391096
- Study Number(s)
- S1904
Cluster randomized controlled trial of decision support for breast cancer chemoprevention, MiCHOICE
- Journal / Conference
- MethodsX, Volume 16, June 2026, 103957. https://doi.org/10.1016/j.mex.2026.103957
- Year
- 2026
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- 42233054
- PMC
- PMC13224384
- Study Number(s)
- S1600
Flow cytometry method to identify arginase-1 expressing MDSCs
- Journal / Conference
- JAMA Netw Open. 2026;9(7):e2623622. doi:10.1001/jamanetworkopen.2026.23622
- Year
- 2026
- Research Committee(s)
- Symptom Management and Survivorship
- PMID
- 42475098
- PMC
- PMC13386599
- Study Number(s)
- S1600